Newly discovered gene critical to embryo’s first days
A previously unknown gene plays a critical part in the development of the human embryo during the first days of fertilisation, researchers from Karolinska Institutet show. The paper, which is published in the scientific journal Development , describes the molecular mechanisms governing early embryonic development and can help in the understanding of what causes certain kinds of infertility.
In 2015, scientists at Karolinska Institutet discovered that a number of previously unknown genes are active in the embryo during the first days of fertilisation of the egg by the sperm. In the present study, they have identified a new variant of one of these genes – called LEUTX – and observed that it is one of the first to be activated in the embryo.
LEUTX belongs to a family of genes known for controlling anatomical development during the embryonic stage in humans and other organisms. Scientists have now, for the first time, shown that LEUTX potently activates hundreds of other genes involved in embryonic development during the first three days following fertilisation. The study shows that LEUTX is shut off shortly afterwards and remains dormant, probably until death.
“The discoveries provide new information about how the development of the human embryo gets started and how the process is controlled,” says principal investigator Juha Kere , professor at Karolinska Institutet’s Department of Biosciences and Nutrition. “Our results also indicate that LEUTX is one of few genes needed to start the first stages of development.”
The researchers also found that the same genes that are activated by LEUTX are inhibited in the embryo just a few days later by another gene called DPRX. This suggests that both genes have opposing roles in the regulation of the embryo’s development in the next phase, LEUTX by starting the process and DPRX by keeping it under control.
“The next stage in our research is to examine if these genes can explain the causes of certain kinds of infertility and if they have applications in stem cell biology,” says Professor Kere.
The study was a collaborative project by researchers at Karolinska Institutet, the Competence Centre on Health Technologies in Estonia and the University of Basel in Switzerland. It was financed by Karolinska Institutet’s Distinguished Professor Award and the Knut and Alice Wallenberg Foundation along with grants from Karolinska Institutet’s Research Foundations, the Swedish Research Council, the Strategic Research Programme in Diabetes at Karolinska Institutet, the EU Commissions’ SARM project, the ALF partnership between KI and Stockholm County Council, the Ragnar Söderberg Foundation, the Swedish Foundation for Strategic Research, the Åke Wiberg Foundation, the Jane & Aatos Erkko Foundation, the Orion Research Foundation, the Mats Sundin Fellowship in Developmental Health, and the Magnus Bergvall Foundation.
“ The human PRD-like homeobox gene LEUTX has a centra l role in embryo genome activation” , Eeva-Mari Jouhilahti, Elo Madissoon, Liselotte Vesterlund, Virpi Töhönen, Kaarel Krjutškov, Alvaro Plaza Reyes, Sophie Petropoulos, Robert Månsson, Sten Linnarsson,Thomas Bürglin, Fredrik Lanner, Outi Hovatta, Shintaro Katayama, Juha Kere, Development , 2016, doi:10.1242/dev.134510
For more information, please contact:
Juha Kere, Professor
Department of Biosciences and Nutrition
Phone: +46 8 524 810 57
Contact the Press Office and download photo: ki.se/pressroom
Karolinska Institutet is one of the world's leading medical universities. Its vision is to significantly contribute to the improvement of human health. Karolinska Institutet accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country´s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.